Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial

NCT07203638 is registered in ClinicalTrials.gov with Esraa Salah Mohamed Abdallah Eladl as lead sponsor.

NCT NCT07203638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial
Lead sponsor
Esraa Salah Mohamed Abdallah Eladl
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 1, 2024
Completion date
November 1, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator-associated pneumonia (vap)